Gene · 9436
Papers3,322
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,322
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immune System and Hepatocellular Carcinoma (HCC): New Insights into HCC Progression. | Int J Mol Sci | 2023 | 37511228 | PubTator, text mining | PubMed |
| Impact of T Lymphocytes Isolated from Liver Perfusate of Deceased Brain Donors on Kidney Transplantation: Preliminary Evidence and Future Directions. | J Clin Med | 2023 | 37510901 | PubTator, text mining | PubMed |
| Polymorphisms of Killer Ig-like Receptors and the Risk of Glioblastoma. | J Clin Med | 2023 | 37510895 | PubTator, text mining | PubMed |
| Intravenous Immunoglobulin in Kawasaki Disease-Evolution and Pathogenic Mechanisms. | Diagnostics (Basel) | 2023 | 37510082 | PubTator, text mining | PubMed |
| The Emerging Role of Innate Lymphoid Cells (ILCs) and Alarmins in Celiac Disease: An Update on Pathophysiological Insights, Potential Use as Disease Biomarkers, and Therapeutic Implications. | Cells | 2023 | 37508573 | PubTator, text mining | PubMed |
| Insight into Cancer Immunity: MHCs, Immune Cells and Commensal Microbiota. | Cells | 2023 | 37508545 | PubTator, text mining | PubMed |
| Role of Interleukin(IL)-6 in NK Activity to Hypoxic-Induced Highly Invasive Hepatocellular Carcinoma(HCC) Cells. | J Microbiol Biotechnol | 2023 | 37501379 | PubTator, text mining | PubMed |
| Predicting diagnostic biomarkers associated with immune infiltration in Crohn's disease based on machine learning and bioinformatics. | Eur J Med Res | 2023 | 37496049 | PubTator, text mining | PubMed |
| Editorial: Cell network in antitumor immunity of pediatric and adult solid tumors. | Front Immunol | 2023 | 37483600 | PubTator, text mining | PubMed |
| A new method for oral cancer biomarkers detection with a non-invasive cyto-salivary sampling and rapid-highly sensitive ELISA immunoassay: a pilot study in humans. | Front Immunol | 2023 | 37483588 | PubTator, text mining | PubMed |
| Good manufacturing practice production of CD34+ progenitor-derived NK cells for adoptive immunotherapy in acute myeloid leukemia. | Cancer Immunol Immunother | 2023 | 37477653 | PubTator, text mining | PubMed |
| NK cell phenotypic profile during active TB in people living with HIV-evolution during TB treatment and implications for bacterial clearance and disease severity. | Sci Rep | 2023 | 37474556 | PubTator, text mining | PubMed |
| Defining the role of natural killer cells in COVID-19. | Nat Immunol | 2023 | 37460639 | PubTator, text mining | PubMed |
| NEDD8-activating enzyme inhibition potentiates the anti-myeloma activity of natural killer cells. | Cell Death Dis | 2023 | 37460534 | PubTator, text mining | PubMed |
| In vitro models to study natural killer cell dynamics in the tumor microenvironment. | Front Immunol | 2023 | 37457703 | PubTator, text mining | PubMed |
| HLA-DP on Epithelial Cells Enables Tissue Damage by NKp44+ Natural Killer Cells in Ulcerative Colitis. | Gastroenterology | 2023 | 37454979 | PubTator, text mining | PubMed |
| Accumulation of tissue-resident natural killer cells, innate lymphoid cells, and CD8+ T cells towards the center of human lung tumors. | Oncoimmunology | 2023 | 37448786 | PubTator, text mining | PubMed |
| Generation and Functional Characterization of Anti-CD19 Chimeric Antigen Receptor-Natural Killer Cells from Human Induced Pluripotent Stem Cells. | Int J Mol Sci | 2023 | 37445684 | PubTator, text mining | PubMed |
| Association of NK Cells with the Severity of Fibrosis in Patients with Chronic Hepatitis C. | Diagnostics (Basel) | 2023 | 37443584 | PubTator, text mining | PubMed |
| The impact of the use of immunosuppressive treatment after an embryo transfer in increasing the rate of live birth. | Front Med (Lausanne) | 2023 | 37441690 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9436/papers?page=13